Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats

被引:0
|
作者
Marques, M
Millás, I
Jiménez, A
García-Colis, E
Rodriguez-Feo, JA
Velasco, S
Barrientos, A
Casado, S
López-Farré, A
机构
[1] Fdn Jimenez Diaz, Cardiovasc & Hypertens Res Lab, E-28040 Madrid, Spain
[2] Hosp Clin U San Carlos, Dept Nephrol, Madrid, Spain
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Low-level lead exposure is a known cause of hypertension that has been associated with increased reactive oxygen species activity and endothelial-dependent vasorelaxation impairment. The effect of lead exposure on the vascular nitric oxide (NO)/cyclic guanocine monophosphate (cGMP) system was analyzed. Wistar rats were exposed to 5 ppm lead acetate in the drinking water during 30 d. Mean arterial BP increased significantly in the lead-treated rats. Relaxation to both acetylcholine and sodium nitroprusside (SNP) was reduced in lead-treated rats: however. the vascular wall of lead-administered rats showed an increased expression of endothelial NO synthase. The expression of both subunits (alpha (1) and beta (1)) of soluble guanylate cyclase (sGC) and the cGMP accumulated in the vascular wall were decreased in lead-treated rats. Cotreatment of lead with vitamin C (3 mmol/L) prevented the increase on mean arterial BP. improved the relaxation to both acetylcholine and sodium nitroprusside, and restored the normal expression of endothelial NO synthase and sGC proteins in the vascular wall. In conclusion, lead exposure altered both the endothelium-dependent and -independent relaxing response and induced a reduced expression of sGC in the vascular wall. These effects were abrogated with the antioxidant vitamin C. which suggests the involvement of reactive oxygen species in the regulation of the NO/cGMP relaxing system in the vascular wall of lead-treated rats.
引用
收藏
页码:2594 / 2600
页数:7
相关论文
共 50 条
  • [41] The soluble guanylate cyclase pathway is dysregulated in rodent models of cirrhosis and portal hypertension
    Sorz-Nechay, Thomas
    Brusilovskaya, Ksenia
    Koenigshofer, Philipp
    Hofer, Benedikt
    Petrenko, Oleksandr
    Simbrunner, Benedikt
    Taru, Vlad
    Zinober, Kerstin
    Regnat, Katharina
    Bonitz, Katharina
    Horstmeier, Henriette
    Truebenbach, Ines
    Sun, Peng
    Kauschke, Stefan Guenther
    Pfisterer, Larissa
    Trauner, Michael
    Schwabl, Philipp
    Reiberger, Thomas
    JOURNAL OF HEPATOLOGY, 2024, 80 : S197 - S197
  • [42] Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice
    Buys, Emmanuel S.
    Raher, Michael J.
    Kirby, Andrew
    Mohd, Shahid
    Baron, David M.
    Hayton, Sarah R.
    Tainsh, Laurel T.
    Sips, Patrick Y.
    Rauwerdink, Kristen M.
    Yan, Qingshang
    Tainsh, Robert E. T.
    Shakartzi, Hannah R.
    Stevens, Christine
    Decaluwe, Kelly
    Rodrigues-Machado, Maria da Gloria
    Malhotra, Rajeev
    Van de Voorde, Johan
    Wang, Tong
    Brouckaert, Peter
    Daly, Mark J.
    Bloch, Kenneth D.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (06): : 2316 - 2325
  • [43] Thymoquinone Improves Lead-Induced Hematotoxicity in Rats
    Mabrouk, Aymen
    PAKISTAN JOURNAL OF ZOOLOGY, 2022, 54 (04) : 1563 - 1568
  • [44] Soluble guanylate cyclase stimulators for the treatment of hypertension: Discovery of MK-2947
    Brockunier, Linda
    Stelmach, John
    Guo, Jian
    Spencer, Tracy
    Rosauer, Keith
    Bansal, Alka
    Cai, Sheng-Jian
    Chen, Nancy
    Cummings, John
    Huang, Li
    Johnson, Timothy
    Levesque, Sonia
    Luo, Lin
    Maloney, Kevin
    Metzger, Joseph
    Mortko, Christopher
    Ortega, Karen
    Pai, Lee-Yuh
    Pereira, Antonio
    Salituro, Gino
    Shang, Jackie
    Shepherd, Cherrie
    Xu, Shiyao Sherrie
    Yang, Qifeng
    Cui, Jisong
    Roy, Sophie
    Parmee, Emma
    Raghavan, Subharekha
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (21)
  • [45] Stimulation of soluble guanylate cyclase affects cardiac fibrosis in angiotensin II-induced hypertensive rats
    Masuyama, Hiroyuki
    Tsuruda, Toshihiro
    Kato, Johji
    Imamura, Takuroh
    Asada, Yujiro
    Stasch, Johannes-Peter
    Kitamura, Kazuo
    Eto, Tanenao
    JOURNAL OF HYPERTENSION, 2006, 24 : 140 - 140
  • [46] Retinal vascular effects of novel soluble guanylate cyclase activator (sGCa) runcaciguat
    Nassar, Khaled
    Schubert, William
    Xu, Zhenhua
    Terjung, Carsten
    Zhou, Lingli
    Guerra, James
    Rheindorf, Katja
    Eilken, Hanna M.
    Duh, Elia J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [47] cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue
    Papapetropoulos, A
    Cziraki, A
    Rubin, JW
    Stone, CD
    Catravas, JD
    JOURNAL OF CELLULAR PHYSIOLOGY, 1996, 167 (02) : 213 - 221
  • [48] The Novel Soluble Guanylate Cyclase Activator PPCA Reverses Acute Hypoxia-induced Pulmonary Hypertension in Dogs
    Wang, Tao
    McCefferty, Gerald P.
    Schnackenberg, Christine G.
    Jucker, Beat M.
    Willette, Robert N.
    Behm, David J.
    FASEB JOURNAL, 2010, 24
  • [49] Thymoquinone attenuates lead-induced nephropathy in rats
    Mabrouk, Aymen
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2019, 33 (01)
  • [50] The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats
    Reinke, Yvonne
    Gross, Stefan
    Eckerle, Lars G.
    Hertrich, Isabel
    Busch, Mathias
    Busch, Raila
    Riad, Alexander
    Rauch, Bernhard H.
    Stasch, Johannes-Peter
    Doerr, Marcus
    Felix, Stephan B.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 767 : 1 - 9